Academic literature on the topic 'Lune serum'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lune serum.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lune serum"

1

Joshi, Gajanand, R. K. Vyas, Ghanshyam Gahlot, and Yogita Soni. "Altered Level of Serum Magnesium in Patients with Esophageal and Lung Carcinoma." International Journal of Life- Sciences Scientific Research 3, no. 4 (2017): 1158–61. http://dx.doi.org/10.21276/ijlssr.2017.3.4.10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Preeti, Sharma, Mathur Keerti, Sharma Rakesh, and Sankhla Manisha. "SERUM CORTISOL LEVEL IN LUNG CANCER PATIENTS AT VARIOUS STAGES OF DIAGNOSIS." International Journal of Basic & Applied Physiology 3, no. 1 (2014): 67–69. https://doi.org/10.5281/zenodo.4476014.

Full text
Abstract:
Background & Objectives: Lung cancer is the leading cause of death in developed countries and is rising in alarming rates in developing countries. Diagnosis of lung cancer is a form of psychological stress, so there may be neuroendocrine alteration in these patients like elevated serum cortisol level, as cortisol is considered as ‘stress hormone’. The study was designed to compare the serum cortisol levels in lung cancer patients at various stages of diagnosis. Methods: The study was conducted in 3 sub groups of lung cancer patients (n=150) and controls (n=150) in Upgraded Department of Physiology, S.M.S.Medical College, Jaipur to estimate serum cortisol level by ELISA (Enzyme Linked Immuno Sorbent Assay) method. Results: The mean serum cortisol levels were highest in sub group A (676.82 nmol/l) followed by sub group B (557.27 nmol/l) and sub group C (236.61 nmol/l). These differences were found highly significant on application of ANOVA (p<0.0001). Interpretation & Conclusion: The level of serum cortisol was highest in newly diagnosed lung cancer patients. The data obtained also indicate that the high cortisol level is due to more psychological disturbances in newly diagnosed patients.
APA, Harvard, Vancouver, ISO, and other styles
3

Ambar, Prakash, Sharma Dhawal, and Wadhawan Gaurav. "A Comparative Study of Laparoscopic Vs Open Surgery for the Management of Duodenal Perforation." International Journal of Pharmaceutical and Clinical Research 15, no. 11 (2023): 1256–62. https://doi.org/10.5281/zenodo.11234944.

Full text
Abstract:
<strong>Introduction:</strong>&nbsp;The digestive duodenum has four parts. Rare but dangerous duodenal perforation is caused by peptic ulcer disease. Serum amylase, serum gastrin, leukocytosis, and C-reactive protein levels are evaluated for diagnosis. There are a variety of surgical and endoscopic treatment techniques available, and choosing one relies on whether or not the perforation is confined. Laparoscopic repair improves patient recovery and appearance. Still, its utility is disputed.&nbsp;<strong>Aims and Objectives:</strong>&nbsp;This research will evaluate laparoscopic duodenal perforation therapy to reduce mortality and improve patient outcomes.&nbsp;<strong>Method:&nbsp;</strong>Laparoscopy and exploratory laparotomy were compared for duodenal perforations in acute abdominal pain and peritonitis patients in a randomised clinical study. Participants were 15&ndash;70 years old with particular clinical markers. After ethics committee approval, 30 patients were randomly allocated to each group. Secondary outcomes included complications, recuperation time, and long-term follow-up. Primary outcomes measured surgical success.&nbsp;<strong>Result:&nbsp;</strong>Table 1 shows that the Laparoscopic and open-method groups have similar patient numbers and modest gender distribution differences. Table 2 shows similar smoking rates but a slightly greater acid-peptic disease frequency in the Laparoscopic group. Table 3 reveals intra-operative findings: longer mean time, higher liver damage, and a few laparotomy conversions in the laparoscopic group. Table 4 shows that laparoscopic surgery results in faster recovery, fewer respiratory issues, fewer infections, and less long-term adhesion obstruction than the Open Method.&nbsp;<strong>Conclusion:</strong>&nbsp;Laparoscopic perforated duodenal ulcer therapy reduces mortality, treatment length, and expenses, according to this study. Lower incisions reduce infection risk, and post-operative adhesions, and improve lung function and patient comfort. &nbsp; &nbsp;
APA, Harvard, Vancouver, ISO, and other styles
4

Gaur, Priyanka, Sarika Pandey, Sandeep Bhattacharya, et al. "Association of Serum CRP level with Lung Cancer and Healthy Control of North Indian Population." International Journal of Life-Sciences Scientific Research 4, no. 2 (2018): 1698–702. http://dx.doi.org/10.21276/ijlssr.2018.4.2.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hou, Yu-Lei, Jian-Hong Zhang, Jin-Bao Guo, and Hui Chen. "Clinical significance of serum S100A10 in lung cancer." Journal of International Medical Research 49, no. 10 (2021): 030006052110496. http://dx.doi.org/10.1177/03000605211049653.

Full text
Abstract:
Objective To investigate the clinical significance of serum S100 calcium-binding protein A10 (S100A10) levels in lung cancer. Methods This prospective study enrolled patients with lung cancer, patients with benign lung nodules and healthy control subjects. Serum S100A10 levels and three biomarkers were measured and compared between the groups. Associations between serum S100A10 and clinical characteristics in patients with lung cancer were investigated. The diagnostic efficacy of serum S100A10 and carcinoembryonic antigen for lung cancer was calculated. Results The study enrolled 82 patients with lung cancer, 21 with benign lung nodules and 50 healthy controls. Serum S100A10 levels were significantly higher in patients with lung cancer compared with patients with benign lung nodules and healthy control subjects. Serum S100A10 levels of patients with advanced lung cancer were significantly higher than those with early stage disease. Patients with lymph node metastases had significantly higher serum S100A10 levels than patients without lymph node metastases. The cut-off serum S100A10 value for lung cancer detection was 1.34 ng/ml, which had a sensitivity of 48.2%, a specificity of 76.2% and an area under the curve of 0.63. Conclusion Serum S100A10 was significantly correlated with disease stage and lymph node metastasis. It has the potential to be a tumour biomarker for lung cancer.
APA, Harvard, Vancouver, ISO, and other styles
6

Guo, Fei Fei, Shi Jia Cheng, Yi Ning Liu, and Jiu Wei Cui. "The Potential Clinical Significance of the Serum Iron and Ferritin Status in Lung Cancer Patients." Journal of Nutritional Oncology 5, no. 4 (2020): 189–95. http://dx.doi.org/10.34175/jno202004006.

Full text
Abstract:
Background An increasing number of studies have shown that iron, one of the indispensable trace elements in the human body, is closely related to the occurrence and development of cancer. However, few studies have clearly demonstrated the role of the iron levels in lung cancer patients, or the potential effects of inflammation on iron levels. Methods The clinical data for lung cancer patients and non-lung cancer participants were retrospectively analyzed. The serum iron and ferritin levels were measured and compared using a rank-sum test. The correlation between the serum iron/ferritin and C-reactive protein (CRP) was analyzed by rank correlation. The cut-off values for continuous variables were obtained by the receiver operating characteristic curve (ROC) method. An analysis of potential prognostic factors in lung cancer patients was conducted by univariate and multivariate survival analyses. Results The serum iron levels in patients with extensive small-cell lung cancer (SCLC) were lower than those with limited-stage SCLC, and the levels of serum ferritin and CRP in those with extensive SCLC were higher than those with limited-stage SCLC. Similarly, the serum iron levels in patients with stage IV non-small cell lung cancer (NSCLC) were lower than those of patients with stage Ⅰ-Ⅲ disease, and the levels of serum ferritin and CRP in those with stage IV NSCLC were higher than those in stages Ⅰ-Ⅲ. The serum iron level was negatively correlated with the level of CRP, while the serum ferritin level was positively correlated with CRP. The stage of lung cancer, but not the serum iron/ ferritin level, was an independent prognostic factor in lung cancer patients. Conclusions The serum iron and ferritin levels are associated with the staging of lung cancer. The later stages of lung cancer are associated with a lower serum iron level, a higher serum ferritin level, and a higher CRP level. Inflammation may play an important role in regulating the serum iron and ferritin levels in lung cancer patients.
APA, Harvard, Vancouver, ISO, and other styles
7

Sahu, Ramesh Kumar. "Raised serum CEA and CA 19-9 in Lung Cancer in tertiary care hospital in Eastern India." Journal of Medical Science And clinical Research 05, no. 05 (2017): 22598–603. http://dx.doi.org/10.18535/jmscr/v5i5.217.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Aquino, Flavia Cristina Gonçalves de, Thais M. Guedes, Arthur Pires, and Heraldo Possolo de Souza. "Serum biomarkers for lung cancer screening." Revista de Medicina 98, no. 1 (2019): 59–71. http://dx.doi.org/10.11606/issn.1679-9836.v98i1p60-72.

Full text
Abstract:
Lung cancer is by far the leading cause of cancer death among both men and women. Screening patients at high risk of developing lung cancer is a worldwide priority, since it can be cured if diagnosed in early stages. Currently, screening in high risk individuals is made using low dose computed tomography, however, this method may lead to false-positive tests and overdiagnosis. The usefulness of serum biomarkers would be relevant in two situations: 1) the screening of large groups at high risk of developing lung cancer, where the biomarker should be very sensitive and 2) during the investigation of pulmonary nodules, where the biomarker should be very specific. Several serum biomarkers have been tested to work as biomarkers for lung cancer screening. Unfortunately, so far, none of them has come into current clinical practice. In this review, we analyze some of the serum biomarkers described in the last 10 years, evaluating their potential as tools to detect lung cancer, particularly in smokers. The use of serum biomarkers and imaging methods together seems to be a solution to early diagnosis of lung cancer, more efficient treatment and enhanced chance of cure.
APA, Harvard, Vancouver, ISO, and other styles
9

Mousa, Amne, Siebe G. Blok, Dian Karssen, et al. "Correlation between Serum Biomarkers and Lung Ultrasound in COVID-19: An Observational Study." Diagnostics 14, no. 4 (2024): 421. http://dx.doi.org/10.3390/diagnostics14040421.

Full text
Abstract:
Serum biomarkers and lung ultrasound are important measures for prognostication and treatment allocation in patients with COVID-19. Currently, there is a paucity of studies investigating relationships between serum biomarkers and ultrasonographic biomarkers derived from lung ultrasound. This study aims to assess correlations between serum biomarkers and lung ultrasound findings. This study is a secondary analysis of four prospective observational studies in adult patients with COVID-19. Serum biomarkers included markers of epithelial injury, endothelial dysfunction and immune activation. The primary outcome was the correlation between biomarker concentrations and lung ultrasound score assessed with Pearson’s (r) or Spearman’s (rs) correlations. Forty-four patients (67 [41–88] years old, 25% female, 52% ICU patients) were included. GAS6 (rs = 0.39), CRP (rs = 0.42) and SP-D (rs = 0.36) were correlated with lung ultrasound scores. ANG-1 (rs = −0.39) was inversely correlated with lung ultrasound scores. No correlations were found between lung ultrasound score and several other serum biomarkers. In patients with COVID-19, several serum biomarkers of epithelial injury, endothelial dysfunction and immune activation correlated with lung ultrasound findings. The lack of correlations with certain biomarkers could offer opportunities for precise prognostication and targeted therapeutic interventions by integrating these unlinked biomarkers.
APA, Harvard, Vancouver, ISO, and other styles
10

Humbert, Marc, Rose Marie Delattre, Jacques Cerrina, Philippe Dartevelle, Gérald Simonneau, and Dominique Emilie. "Serum Neopterin After Lung Transplantation." Chest 103, no. 2 (1993): 449–54. http://dx.doi.org/10.1378/chest.103.2.449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Lune serum"

1

Sivak-Sears, Niccole R. "The Acute-Phase Response and Cancer Risk." The Ohio State University, 2003. http://rave.ohiolink.edu/etdc/view?acc_num=osu1053636439.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bruhn, Norbert. "Mikrosatellitenalterationen in der Serum-DNA bei Patienten mit Bronchialkarzinom." Doctoral thesis, [S.l. : s.n.], 1999. http://deposit.ddb.de/cgi-bin/dokserv?idn=958164584.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stein, Claudia Elisabeth. "Coronary heart disease, diabetes, serum lipid concentrations and lung function in relation to fetal growth in south India." Thesis, University of Southampton, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.242673.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Parekh, Gita. "Leukocyte-mediated degradation of lung extracellular matrix & serum molecules in chronic inflammatory disease, as discerned through urinary biomarkers." Thesis, Cardiff University, 2018. http://orca.cf.ac.uk/120257/.

Full text
Abstract:
Chronic Obstructive Pulmonary disease (COPD) is an irreversible inflammatory disease of the lung, characterised by abnormal inflammation of the lungs in response to inhalation of noxious particles or toxic gases, especially cigarette smoke. COPD exacerbations, defined as acute sustained worsening of symptoms from usual stable state, accounts for significant morbidity and mortality. Improved diagnostics which give advanced warning of an exacerbation could help prevent further declines in lung function. The quest to identify a marker or a combination of markers associated with COPD exacerbations has been pursued for some time. Many groups have studied biomarkers in plasma, serum, sputum and bronchoalveolar lavage (BAL) fluid and uncovered useful markers for prediction of exacerbations, disease severity and mortality. However, there is limited research on urine biomarkers. Profiling inflammatory mediators in urine samples presents a simple, convenient, non-invasive measure of inflammation in COPD patients and can be done repeatedly within their own home or in the clinic, allowing easier monitoring of time-dependent changes in biomarker levels. The research described in this thesis is the first investigation where a large panel of biomarkers has been evaluated in urine samples from subjects in various stages of COPD. This has provided new insights into the relevance and origin of the biomarkers. Prototype point-of-care tests were developed that could be used routinely by patients in their own homes to monitor their inflammation status and predict pulmonary exacerbations. This was evaluated in a prospective observational study, results of which were used to develop a simple algorithm that showed the potential for differentiating between stable state and exacerbation events. The research described here is part of a major research initiative carried out within the Mologic R&D group and constitutes investigations designed and directed by the author, and conclusions derived from the author's analysis of the data collected by the biomarker immunoassays. The findings constitute a key scientific foundation for a new approach to personalised medicine for COPD sufferers.
APA, Harvard, Vancouver, ISO, and other styles
5

Gelis, Suyin Sonja [Verfasser], and Michael [Akademischer Betreuer] Tachezy. "Tenascin-C-Serum Levels and its Prognostic Power in Non-Small Cell Lung Cancer / Suyin Sonja Gelis ; Betreuer: Michael Tachezy." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2018. http://d-nb.info/1158900066/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tharu, Bhikhari Prasad. "Statistical Analysis and Modeling Health Data: A Longitudinal Study." Scholar Commons, 2016. http://scholarcommons.usf.edu/etd/6413.

Full text
Abstract:
Lung cancer has been considered one of the leading causes of deaths while cancer re- mains the second most common cause of deaths in the USA. Understanding the behavior of a disease over time could yield important information to make decisions about the disease. Statistical models could provide crucial clues and help to make a decision about the dis- ease, budget allocation, evaluation, and implement prevention. Longitudinal trend analysis of the diseases helps to understand long term effects and nature. Cholesterol level is one of the most contributing risk factors for Coronary Heart Disease. Studying cholesterol statistically helps to know more about its nature and provides crucial information to mitigate its effectiveness in diagnosing its impact to public health. In our study, we have analyzed lung cancer mortality in the USA based on age at death, period at death, and birth cohort to investigate its nature in longitudinal effects. The attempt has been made to estimate mortality rate based on age for different age groups and to find the relative risk of mortality due to period effect and relative risk due to birth cohort for lung cancer in the United States. Our statistical analysis and modeling are based on the data obtained from Surveillance Epidemiology and End Results (SEER) program of the United States. We have also investigated the probabilistic behavior of average cholesterol level based on gender and ethnicity. The study reveals significant differences with respect to the distribution they follow and their basic inferences which could be beneficial to draw conclusions in various ways in addressing related issues. At the same time, the change of cholesterol level over time for an individual might be a good source to study the association of cholesterol level, coronary heart disease and their effects on age. The cholesterol data is obtained from inter-university Consortium for Political and Social Research and National Health and Nutrition Examination Survey (NHANS) of the United States. Understanding the average change in total serum cholesterol level over time as people get older could be vital to explore it. We have studied the longitudinal behavior of the association of sex and time with cholesterol level. It is observed that age, sex, and time have an individual effect and can impact differently upon collective considerations. Their adverse effect in increasing cholesterol level could promote to worsen the cholesterol re- lated issues and hence heart related diseases. We believe our study pivots knowing more about target population of cholesterol level and helps to have the useful inference about cholesterol levels for public health. Finally, we also analyzed the average cholesterol data using a functional data analysis approach to understand its nature and effect on age. Since functional data analysis approach presents more flexibility in modeling, it could provide more insight in studying cholesterol level.
APA, Harvard, Vancouver, ISO, and other styles
7

Hoppe, Hans-Juergen. "Expression of human lung surfactant protein D and serium C1q : studies on the structure and function of the neck-region domain SP-D." Thesis, University of Oxford, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.259951.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Masago, Katsuhiro. "Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer." Kyoto University, 2009. http://hdl.handle.net/2433/124291.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wiemeyer, Stefan [Verfasser], Friedrich [Akademischer Betreuer] Schöndube, Lars [Akademischer Betreuer] Lüthje, and Martin [Akademischer Betreuer] Oppermann. "Der Stellenwert der LDH-5-Exprimierung im Tumor sowie der Serum-LDH als Tumormarker für das Plattenepithelkarzinom der Lunge / Stefan Wiemeyer. Gutachter: Friedrich Schöndube ; Lars Lüthje ; Martin Oppermann. Betreuer: Friedrich Schöndube." Göttingen : Niedersächsische Staats- und Universitätsbibliothek Göttingen, 2011. http://d-nb.info/1042690707/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Berrocal, Almanza Luis Carlos [Verfasser]. "The impact of the serum levels of soluble receptor for advanced glycation end products (sRAGE) and its ligand S100A12 for the course and extent of lung involvement in smear positive pulmonary tuberculosis in a cohort study in Hyderabad - India. / Luis Carlos Berrocal Almanza." Berlin : Freie Universität Berlin, 2015. http://d-nb.info/1070570729/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Lune serum"

1

Stockley, Robert A. Serum and secretion proteins in chronic lung disease. University of Birmingham, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Plönes, Till. Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas. Universität, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Clement, Jan. Acute kidney injury and hantavirus disease. Edited by Norbert Lameire. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0242_update_001.

Full text
Abstract:
Hantavirus disease or at least its renal form, the so-called haemorrhagic fever with renal syndrome is the only globally emerging acute kidney injury (AKI) form, and currently without doubt the most underestimated form of community-acquired AKI. Hantavirus disease is a viral zoonosis, caused by inhalation of infectious aerosolized excreta from chronically infected rodents, which are both the reservoir and the vector of different hantavirus species. Clinical presentation consists of sudden flu-like symptoms (fever, headache, myalgia), followed by gastrointestinal discomfort and AKI, often with anuria or oliguria. More rarely, acute myopia and/or non-cardiogenic acute lung oedema or injury is the presenting or complicating symptom. Laboratory hallmarks are initial thrombocytopenia and proteinuria, raised C-reactive protein and lactate dehydrogenase, left-shift leucocytosis, and typical but transient serum lipid disturbances. Spontaneous remission occurs within 2–3 weeks without sequelae. Case fatality rate is between 0.1% and 15% according to the infecting hantavirus species, but most infections show in fact an asymptomatic or paucisymptomatic presentation. Treatment is only supportive, but may necessitate life-saving intensive care techniques. Together with leptospirosis, haemorrhagic fever with renal syndrome is the only form of AKI against which different vaccines are in use, but a World Health Organization-licensed hantavirus vaccine is still lacking.
APA, Harvard, Vancouver, ISO, and other styles
4

Denton, Christopher P., and Pia Moinzadeh. Systemic sclerosis. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0121.

Full text
Abstract:
The term 'scleroderma' describes a group of conditions in which the development of thickened, fibrotic skin is a cardinal feature. This includes localized forms of scleroderma (e.g. morphoea) and also systemic forms of the disease that are more correctly termed systemic sclerosis. Systemic sclerosis (SSc) is a multiorgan, autoimmune disease that has a high clinical burden and mortality, due to affecting the skin as well as internal organs. As with other related diseases there is a female predominance and marked clinical diversity. The pathogenesis of SSc is not fully elucidated; it includes endothelial cell injury fibroblast activation and autoimmunity that lead to skin and internal organ manifestations. The majority of cases exhibit characteristic serum autoantibodies. Some of these antibodies are scleroderma-specific reactivities including anti-centromere (ACA), anti-topoisomerase-1 (ATA or Scl 70) or anti-RNA polymerase III antibodies. These anti-nuclear antibody (ANA) patterns are generally mutually exclusive and serve as useful clinical markers of disease subgroups. Additional subsetting of scleroderma cases, based on the extent of skin sclerosis, permits classification into limited and diffuse subsets. Because of the heterogeneity of the disease patients may suffer from different organ manifestations, such as lung fibrosis, hypertensive renal crisis, severe cardiac disease, gastrointestinal involvement, and pulmonary arterial hypertension. Although outcomes have improved recently, systemic sclerosis still has the highest case-specific mortality of any of the autoimmune rheumatic diseases and requires careful and systematic investigation, management and follow-up. Treatment includes symptomatic strategies with attention to each involved organ system; it is still an area where therapeutic progress and better understanding of pathogenesis is increasingly anticipated.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Lune serum"

1

Hassanein, Mohamed, and David P. Carbone. "Serum Proteomic Biomarkers." In Lung Cancer. John Wiley & Sons, Inc., 2014. http://dx.doi.org/10.1002/9781118468791.ch5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Luna, Carlos M. "Bronchoalveolar and Serum Markers of Lung Disease." In Diffuse Lung Disorders. Springer London, 1999. http://dx.doi.org/10.1007/978-1-4471-3440-4_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Eestermans, G., H. E. Demey, and M. E. De Broe. "Serum Markers in Acute Lung Injury." In Update in Intensive Care and Emergency Medicine. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83737-1_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ding, Qingqing, Yuan Mu, Shiyang Pan, et al. "Plasma DNA Methylation Analysis in Predicting Short-Term Recurrence of Surgical Patients with Non-small Cell Lung Cancer (NSCLC)." In Circulating Nucleic Acids in Plasma and Serum. Springer Netherlands, 2010. http://dx.doi.org/10.1007/978-90-481-9382-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ponomaryova, Anastasia A., Elena Y. Rykova, Nadezhda V. Cherdyntseva, et al. "Concentration and Distribution of Single-Copy β-Actin Gene and LINE-1 Repetitive Elements in Blood of Lung Cancer Patients." In Circulating Nucleic Acids in Plasma and Serum. Springer Netherlands, 2010. http://dx.doi.org/10.1007/978-90-481-9382-0_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sibille, Yves, and William W. Merrill. "Bronchoalveolar and Serum Markers of Lung Disease." In Radiologic Diagnosis of Chest Disease. Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-0347-3_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Le Flour, N., S. Jouveshomme, and J. P. Derenne. "Bronchoalveolar and Serum Markers of Lung Disease." In Radiologic Diagnosis of Chest Disease. Springer London, 2001. http://dx.doi.org/10.1007/978-1-4471-0693-7_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Molteni, Agostino, William F. Ward, Yoon T. Kim, et al. "Serum Copper Concentration as an Index of Clinical Lung Injury." In Copper Bioavailability and Metabolism. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0537-8_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ward, William F., Agostino Molteni, Chung-hsin Ts’ao, and Harry Ischiropoulos. "Serum Copper Concentration as an Index of Experimental Lung Injury." In Copper Bioavailability and Metabolism. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0537-8_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Knekt, P., G. Alfthan, A. Aromaa, et al. "Low Serum Selenium Level and Elevated Risk of Lung Cancer." In Selenium in Biology and Medicine. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-74421-1_59.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lune serum"

1

Alobahi, Asma, Sumaya Yusuf, Zainab Dookhy, and Vijay Ganji. "Vitamin D is associated with Improved Lung Function But Not with Asthma, Emphysema and Bronchitis." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0225.

Full text
Abstract:
Background: Hypovitaminosis D has been linked to several non-bone related diseases. Relation between serum 25-hydroxyvitamin D [25(OH)] and lung function and lung diseases has received less attention. Methods: Data from 3 National Health and Nutrition Examination Survey (NHANES) cycles, 2007-2012 were used. The sample size was 11983. Lung function markers such as forced vital capacity (FVC)and forced expiratory volume in 1 second (FEV1) were collected with Spirometry. Relation between serum 25(OH)D and lung function makers was assessed by the multivariate regression. Relation between serum 25(OH)D and prevalence of asthma, emphysema, and chronic bronchitis were assessed with multivariate-adjusted logistic regression. Results: Serum 25(OH)D was significantly associated with FVC and FEV1 (P &lt;0.001). When data were stratified based on sex and smoking status, we found similar associations between serum 25(OH)D and lung function markers. No relation was found between serum 25(OH)D and prevalence of asthma, chronic bronchitis, and emphysema. Conclusions: Serum 25(OH)D is significantly associated with improved lung function markers. Controlled studies are needed to determine if improved serum 25(OH)D will improve the lung function in adults.
APA, Harvard, Vancouver, ISO, and other styles
2

Vera-Santiesteban, Elsie, Marta Gabasa, Yasmina Gutiérrez-Rodríguez, et al. "Serum biomarkers in ILA and familial Early ILD." In ERS Lung Science Conference 2025 abstracts. European Respiratory Society, 2025. https://doi.org/10.1183/23120541.lsc-2025.tp324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Li, Xiaozhou, Huiqiang Jin, Huasheng Liu, Jianhua Ding, and Junxiu Lin. "Spectral Characteristic Analysis of Lung Cancer Serum." In European Conference on Biomedical Optics. Optica Publishing Group, 2001. http://dx.doi.org/10.1364/ecbo.2001.4432_257.

Full text
Abstract:
Spectral changes of lung cancer serum in the process of tumor evolution were investigated in this study. We kept close watch on the tumor progression of a group of patients, and measured their serum spectra using 488.0nm and 514.5nm excitation of an Ar-ion laser once a week. There was no apparent change observed in fluorescence spectrum in different period. However, the relative intensity of three Raman peaks (mode A, B and C) decreased every week later. For quantitative analysis of such changes, a parameter Ir (relative intensity of C Raman peak) was introduced and Ir-value was calculated. Calculation showed that Ir-value was degressive with tumor evolution, but β (Ir5145/Ir4880) varied irregularly. To the end, no Raman peak was observed. We assumed that three Raman peaks were derived from beta carotene. It indicated that the content of beta carotene decreased with the aggravation of lung cancer.
APA, Harvard, Vancouver, ISO, and other styles
4

Machahua Huamani, C. E., N. Abu Hussein, and M. Funke-Chambour. "Pulmonary impaired COVID-19 patients show pro-fibrotic serum biomarkers after 4 months." In ERS Lung Science Conference 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.lsc-2023.56.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Vanoverschelde, Anna, Samer R. Khan, Virgil A. S. H. Dalm, et al. "Association between serum IgG levels and time to first antibiotic prescription in COPD patients." In ERS Lung Science Conference 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/23120541.lsc-2022.58.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hummersgaard Hansen, A., J. H. Mortensen, M. Karsdal, et al. "A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF." In ERS Lung Science Conference 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/23120541.lsc-2021.86.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bartoli, Gabriele, Alberto Ricci, and Andrea Mazza. "Serum Levels of Surfactant Protein-B (SP-B) as biomarker in IPF and ILD-SSc." In ERS Lung Science Conference 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/23120541.lsc-2022.145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kalafatis, D., A. Löfdahl, P. Näsman, L. Elowsson Rendin, G. Westergren-Thorsson, and M. Sköld. "Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF." In ERS Lung Science Conference 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/23120541.lsc-2021.59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Li, Xiao Zhou, Huiqiang Jin, Huasheng Liu, Jianhua Ding, and Junxiu Lin. "Spectral characteristic analysis of lung cancer serum." In European Conference on Biomedical Optics, edited by Theodore G. Papazoglou and Georges A. Wagnieres. SPIE, 2001. http://dx.doi.org/10.1117/12.447146.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Morlacchi, Letizia Corinna, Valeria Rossetti, Marco Mantero, et al. "Serum cytokines patterns in lung transplant recipients." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa1790.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Lune serum"

1

Lin, Yunkai, Canjia Zhang, Jia Xu, et al. Dietary intake and serum level of folate and lung cancer risk: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.11.0033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Qiao, Feng. Association between microRNA 21 expression in serum and lung cancer: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.4.0055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Qiao, Feng. Association between microRNA 25 expression in serum and lung cancer: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.4.0056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Xie, Sisi, Shu Li, Bilin Chen, Qing Zhu, Lichang Xu, and Fen Li. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-associated interstitial lung disease: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.4.0071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

He, Xing, Jiaqi Ji, Xixi Chen, et al. Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.11.0008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

He, Xing, Jiaqi Ji, Dan Zheng, Zeli Luo, Linjie Luo, and Lu Guo. Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation and mortality in patients with interstitial lung disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.5.0050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography